IL6 and rheumatoid arthritis: Our results indicated that MASM could significantly inhibit the production of pro-inflammatory cytokines (TNF-α, IL-6, and IL-8) and MMPs (MMP-1, MMP-3, and MMP-13) in RA-FLS in a dose-dependent manner (Fig. 3B).